This study showed that levels of PGP9.5 mRNA were similar to normal thyroid tissues in other thyroid cancers including anaplastic, papillary, and follicular carcinomas as well as follicular adenoma, suggesting that overexpression of PGP9.5 could not be used as a biomarker for these cancers. Here, UCHL1 is linked to thyroid gland carcinoma.